Current Affairs

Last October I wrote about “Riding a Bike Versus the Hard Part” after riding in a 3-day event where I met many patients, their friends and family and the challenges they face every day. Leading up to both of these rides on the East and...

AI vs MD: What it means for Pathology By David West, CEO, Proscia Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human...

Hørsholm, Denmark, May 3rd - Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep...

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop...

Proscia continues to demonstrate the potential for its technology demonstrating agreement between its algorithms and pathologist reads in detection and classification of breast cancer. Proscia Inc., a data and analytics solutions provider for...

OR

platinum partners

gold partners

Silver Partners

Media Partners